NHS is set to treat hundreds of cancer patients with an innovative type of radiotherapy
The first centres to treat patients with stereotactic ablative radiotherapy (SABR), as part of NHS England’s latest national evaluation programme, will be able to start accepting patients from this week.
NHS England has invested £15m over three years to assess the use of SABR through its “commissioning through evaluation” initiative, which will allow up to 750 new patients a year to access the treatment at 17 centres across the country. More .....
